Samylla Maira Costa Siqueira* and Sarazete Izidia Vaz Pereira
Objective: To identify evidence in the scientific literature about pharmacological therapy for COVID-19 in pediatrics.
Methods: This is an integrative literature review, conducted using the spider tool and performed in June 2020, at PubMed using the descriptors “coronavirus infections, child and drug therapy”. After filtering from the inclusion and exclusion criteria, five articles summarized in synoptic tables were used and analyzed using an instrument.
Results: The selected articles pointed to the use of antiviral drugs (Lopinavir-Ritonavir (LPV/r), antibiotics (Vancomycin and Amikacin), antimalarial (hydroxychloroquine), immunomodulatory (interferon α-1b) and herbal medicine (lianhuaqingwen) in the pharmacological management of children with COVID-19.
Conclusion: Because it is a new strain of coronavirus, it is necessary to conduct clinical studies that guide evidence-based practice.
Published Date: 2024-07-29; Received Date: 2020-07-24
